Trial Profile
A Study to Determine the Effects of MK0557 in Obese Subjects
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 May 2022
Price :
$35
*
At a glance
- Drugs MK 0557 (Primary)
- Indications Obesity
- Focus Therapeutic Use
- Sponsors Merck Sharp & Dohme
- 12 May 2014 New trial record